FH clinical phenotype in Greek patients with LDL‐R defective vs. negative mutations

Abstract

The homogenous molecular basis of familial hypercholesterolaemia in Greece facilitates the application of a DNA diagnostic strategy based on the origin of the patient. The early mutation analysis would add valuable information on the severity of the disease.